Advances in Chronic Obstructive Pulmonary Disease Imaging

Advances in Chronic Obstructive Pulmonary Disease Imaging

Chest computed tomography (CT) imaging is a useful gizmo that gives in vivo data relating to lung construction. Imaging has contributed to a greater understanding of COPD, permitting for the detection of early structural modifications and the quantification of extra-pulmonary buildings. Novel CT imaging methods have supplied perception into the development of the primary COPD subtypes, corresponding to emphysema and small airway illness. This research goals to research the scientific worth of serum Klotho and FGF23 in cardiac valve calcification in sufferers with power kidney illness (CKD).

This text serves as a overview of latest data related to COPD imaging. CT abnormalities, corresponding to emphysema and lack of airways, are current even in people who smoke who don’t meet the factors for COPD and in these with mild-to-moderate illness. Topics with mild-to-moderate COPD, with the best lack of airways, additionally expertise the best decline in lung operate. Additional-pulmonary manifestations of COPD, The pattern of the research was decided by way of energy evaluation, sufferers have been assigned teams utilizing a easy random sampling methodology. The information have been collected between December 2019-June 2020.

corresponding to proper ventricle enlargement and low muscle mass measured on CT, are related to elevated danger for all-cause mortality. CT longitudinal knowledge has additionally given perception into the development of COPD. Mechanically affected areas of lung parenchyma adjoining to emphysematous areas are related to a higher decline in FEV1. Topics with the best proportion of small airway illness, as measured on matched inspiratory-expiratory CT scan, additionally current with the best decline in lung operate.  This research was carried out for the goal of assessing the impact of nursing care utilized to sufferers with power obstructive pulmonary illness on their sexual experiences and high quality of life.

The researcher utilized the nursing care to sufferers within the experimental group of their dwelling thrice. There was a statistically important distinction between posttest imply scores of the Brief Kind-36 Well being-Associated High quality of Life Questionnaire subscales and Arizona Sexual Experiences Scale of the sufferers within the experimental and management teams (p < 0.05). On this research, it was decided that there was a rise within the Well being-Associated High quality of Life Questionnaire imply rating of sufferers with COPD after the nursing care; whereas, there was a slight lower within the Arizona Sexual Experiences Scale imply rating.

Advances in Chronic Obstructive Pulmonary Disease Imaging

The Scientific Worth of Klotho and FGF23 in Cardiac Valve Calcification Amongst Sufferers with Power Kidney Illness

Within the current research, 180 sufferers with CKD, who have been admitted to the division of nephrology of our hospital on April 1, 2016 (solstice, 2019), have been chosen as the primary topics. In line with the CKD stage, these sufferers have been divided into three teams: CKD2~three group, CKD4 group, and CKD5 group. In every group, ultrasound was used to judge the cardiac valve calcification, and the impartial danger components for cardiac valve calcification have been analyzed by Logistic regression. Cultures yielded considerable development of Corynebacterium spp., together with Corynebacterium jeikeium (n = 2), Corynebacterium glucuronolyticum (n = 1), and a multidrug-resistant Corynebacterium striatum isolate (n = 1).
The degrees of hemoglobin and blood calcium in CKD2~three sufferers have been larger than these in CKD4 and CKD5 sufferers, and the degrees of hemoglobin and blood calcium in CKD5 sufferers have been larger than these in CKD4 sufferers (P<0.05). Albumin was decrease in CKD2~three sufferers when in comparison with CKD5 sufferers whereas albumin was larger in CKD5 sufferers when in comparison with CKD4 sufferers (P<0.05). Moreover, the serum ranges of FGF23 and Klotho are affected by numerous components, and the degrees of FGF23 and Klotho in CKD sufferers are negatively correlated. GFR, serum creatinine.
The serum ranges of FGF23 was decrease in CKD2~three sufferers when in comparison with CKD4 and CKD5 sufferers whereas the serum ranges of FGF23 was decrease in CKD4 sufferers when in comparison with CKD5 sufferers (P<0.05). The serum ranges of Klotho was larger in CKD2~three sufferers, when in comparison with CKD4 and CKD5 sufferers, whereas the serum ranges of Klotho was larger in CKD4 sufferers, when in comparison with CKD5 sufferers (P<0.05). The logistic regression evaluation revealed that GFR, serum creatinine, FGF23 and Klotho have been impartial danger components for cardiac valve calcification in sufferers with CKD.
4 eyes of three sufferers have been included on this overview. Every eye offered with persistent corneal epithelial defect with corneal thinning within the power section of SJS/TEN. Not one of the epithelial defects have been related to stromal infiltration. The corneas have been cultured on the time of workup of persistent epithelial defect (three eyes) or at time of tectonic penetrating keratoplasty after perforation (1 eye). The ocular floor was stabilized with surgical intervention (1 eye) or with introduction of fortified topical antibiotic primarily based on laboratory identification and susceptibility testing of the remoted organisms (three eyes). Quite a few danger components for microbial keratitis have been current in all four eyes.

Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)

Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)

The concentrating on of each the muscarinic and β-adrenergic pathways is a effectively validated therapeutic strategy for the therapy of power obstructive pulmonary illness (COPD). On this communication we report our effort to include two pharmacologies right into a single chemical entity, whose attribute should be appropriate for a as soon as every day inhaled administration. Contextually, we aimed toward a domestically performing remedy with restricted systemic absorption to reduce negative effects. Our lung-tailored desing of bifunctional compounds that mix the muscarinic and β-adrenergic pharmacologies by the elaboration of the muscarinic inhibitor 7, efficiently led to the potent, pharmacologically balanced muscarinic antagonist and β2 agonist (MABA) 13.

Acute kidney harm (AKI) and power kidney illness are widespread interconnected syndromes that symbolize a public well being drawback. Acute kidney illness (AKD) is outlined because the post-AKI standing of acute or subacute kidney injury/dysfunction manifested by persistence of AKI past 7 to 90 days after the preliminary AKI analysis. Restricted scientific knowledge exist concerning AKD epidemiology however its incidence is noticed in ∼25% of AKI survivors. Helpful risk-stratification instruments to foretell danger of AKD and its prognosis are wanted. Interventions on fluid administration, nephrotoxic publicity, and follow-up care maintain promise to ameliorate the burden of AKD and its issues.

Affiliation between power kidney illness (CKD) and ischaemic coronary heart illness (IHD) is well-known. Clinically, due to using intra-arterial distinction, coronary angiograms are generally not carried out to keep away from additional deterioration in kidney operate amongst CKD sufferers. Due to this fact, our purpose is to establish whether or not intervention for non-ST elevation myocardial infarction (NStemi) is related to elevated mortality or additional renal deterioration. Power obstructive pulmonary illness (COPD) is usually accompanied by psychiatric issues, equivalent to despair and anxiousness, affecting each therapy outcomes and mortality. Proof for the variety of COPD sufferers utilizing remedy for these problems is sparse. On this examine, power antidepressant (ATD) and anxiolytic (ANX) drug use – to establish despair and anxiousness – amongst COPD sufferers was in contrast with topics with or with out different power illnesses.

Affiliation between the transtubular potassium gradient and development of power kidney illness: outcomes from KNOW-CKD

The transtubular potassium gradient which displays potassium secretion by the kidney by the cortical gathering duct, has not but been examined as a surrogate marker of kidney operate decline. Right here, we examine the connection between the transtubular potassium gradient and power kidney illness (CKD) development. We studied 1672 sufferers from the KoreaN Cohort Examine for Final result in Sufferers With Power Kidney Illness (KNOW-CKD) cohort. The transtubular potassium gradient was calculated utilizing a regular equation. The examine endpoint was CKD development, outlined as a composite of a ≥ 50% lower in estimated glomerular filtration fee (eGFR) from baseline values or end-stage kidney illness.
Throughout a median follow-up of 4.1 years (7149 person-years), 441 contributors reached the endpoint. In cause-specific competing danger evaluation, the best tertile was related to a considerably decrease danger of an opposed kidney consequence in contrast with the bottom tertile [hazard ratio (HR), 0.73; 95% confidence interval (CI), 0.55-0.97]. When the transtubular potassium gradient was handled as a steady variable, a rise of 1 within the transtubular potassium gradient was related to a 6% decrease danger of CKD development (95% CI, 0.90-0.99). This affiliation was significantly evident in sufferers with an eGFR ≥ 45 mL/min/1.73 m2. A time-updated transtubular potassium gradient mannequin confirmed comparable outcomes.
The predictive efficiency of the transtubular potassium gradient was considerably lower than that of the eGFR, however much like that of proteinuria, serum bicarbonate, and urine osmolality.  The next transtubular potassium gradient is related to a considerably decrease danger of CKD development, suggesting that it might supply insights into the prognosis of CKD. Moreover, the serum ranges of FGF23 and Klotho are affected by numerous components, and the degrees of FGF23 and Klotho in CKD sufferers are negatively correlated. GFR, serum creatinine,
Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)

Significance of Power Illnesses and Smoking Habits within the Improvement of Acute Respiratory Misery Syndrome Amongst Hospitalized COVID-19 Sufferers in Indonesia

Acute respiratory misery syndrome (ARDS) is without doubt one of the important causes of excessive mortality amongst coronavirus illness 2019 (COVID-19) sufferers. This examine aimed toward figuring out the affiliation between presence of power illnesses and smoking behaviors with the event of ARDS amongst hospitalized COVID-19 sufferers in Indonesia. This examine was carried out in 15 Muhammadiyah-‘Aisyiyah-affiliated COVID-19 referral hospitals in Indonesia. 4 hundred ninety contributors who examined constructive for the COVID-19 had been recruited on this examine.

Demographic knowledge, historical past of power illnesses, and the event of ARDS had been retrieved from hospital affected person data. Details about the smoking conduct was collected after respondents had been discharged from the hospital. Presence of power illnesses equivalent to diabetes, power coronary heart illness, hypertension, and power liver illnesses had been considerably related to the event of ARDS. In an analogous regard, sufferers who at present smoked had a 5 occasions higher danger of creating ARDS in contrast with those that by no means smoked.

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNUB2035-500 500uL
EUR 513
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-100 100uL
EUR 264
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-50 50uL
EUR 405
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-500 500uL
EUR 513
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC552035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC552035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC552046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC552046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC612035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC612035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC612046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC612046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC472035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC472035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC472046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC472046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC042035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC042035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC042046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC042046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC052035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC052035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC052046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC052046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC402035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC402035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC402046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC402046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC432035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC432035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC432046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC432046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC702035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC702035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC702046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC702046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC802035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC802035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC802046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC802046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCH2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCH2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCH2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCH2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCP2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), PerCP conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCP2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), PerCP conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCR2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), RPE conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCR2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), RPE conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC942035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC942035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC942046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC942046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCA2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), APC conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCA2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), APC conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCB2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCB2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCB2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCB2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Biotin conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC882035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC882035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC882046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC882046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF488A conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC682035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC682035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC682046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC682046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCAP2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCAP2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCAP2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCAP2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC812035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC812035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC812046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC812046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

Anti-ZAP70 (Chronic Lymphocytic Leukemia Marker) Monoclonal Antibody

M00754-1 100ug/vial
EUR 397
Description: Mouse Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody. Validated in IHC and tested in Human.

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: SPM362

APR14716G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone SPM362. This antibody is applicable in IHC, IF, FC

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: 2F3.2

APR14717G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone 2F3.2. This antibody is applicable in IHC, IF, FC

Cancer MicroRNA qPCR Array

RA610A-1 10 profiles
EUR 1172
  • Category: MicroRNA Tools

Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E02C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E02C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E02C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: ZAP70/528

APR14715G 7 ml
EUR 484
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone ZAP70/528. This antibody is applicable in IHC, IF, FC

Chronic Lymphocytic Leukemia Deletion Region Gene 8 Protein (CLLD8) Antibody

abx430501-200ul 200 ul
EUR 384
  • Shipped within 1-3 working days.

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C.1 0.1 ml
EUR 125

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C.5 0.5 ml
EUR 300

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C1 1 ml
EUR 500

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Many sufferers with power fatigue syndrome (CFS) fail to derive profit from evidence-based remedies equivalent to cognitive-behavioural remedy (CBT) and graded train remedy resulting in everlasting incapacity. To find whether or not a repeat prescription of modafinil would possibly potentiate the advantages of CBT resulting in social restoration as outlined by 2 or extra level enchancment in vitality and muscular ache/focus and return to work or full-time coaching. Three sufferers with treatment-resistant CFS (imply length 17.66 years) handled with modafinil and CBT in a Liaison Psychiatry clinic had been retrospectively reviewed.

 

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state
 Continual obstructive pulmonary illness (COPD) is a progressive, life-threatening lung illness with rising prevalence and incidence worldwide. Rising proof means that lung microbiomes would possibly play a physiological function in acute exacerbations of COPD. The target of this examine was to characterize the affiliation of the microbiota and exacerbation danger or airflow limitation in secure COPD sufferers. To make use of CFF and PHES to measure the prevalence of cerebral dysfunction in people with CKD.
The sputum microbiota from 78 COPD outpatients during times of medical stability was investigated utilizing 16S rRNA V3-V4 amplicon sequencing. The microbiome profiles have been in contrast between sufferers with completely different dangers of exacerbation, i.e., the low danger exacerbator (LRE) or excessive danger exacerbator (HRE) teams, and with completely different airflow limitation severity, i.e., delicate to reasonable (FEV1 ≥ 50; PFT I) or extreme to very extreme (FEV1 < 50; PFT II). BM-MSCs confirmed related morphology, frequency, phenotype, and proliferation in sufferers with or with out cGVHD. MSCs from the lively cGVHD group confirmed a decreased apoptosis fee (P < 0.01).
The bacterial variety (Chao1 and noticed OTUs) was considerably decreased within the HRE group in comparison with that within the LRE group. The highest three dominant phyla in sputum have been Firmicutes, Actinobacteria, and Proteobacteria, which have been related within the HRE and LRE teams. On the genus stage, in comparison with that within the LRE group (41.24%), the proportion of Streptococcus was barely decreased within the HRE group (28.68%) (p = 0.007). Nonetheless, the bacterial variety and the proportion of dominant micro organism on the phylum and genus ranges have been related between the PFT I and PFT II teams.
Moreover, the relative abundances of Gemella morbillorum, Prevotella histicola, and Streptococcus gordonii have been decreased within the HRE group in comparison with these within the LRE group in accordance with linear discriminant evaluation impact measurement (LEfSe). Microbiome community evaluation prompt altered bacterial cooperative regulation in numerous exacerbation phenotypes. The proportions of Proteobacteria and Neisseria have been negatively correlated with the FEV1/FVC worth. In keeping with purposeful prediction of sputum bacterial communities by means of Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) evaluation, genes concerned in lipopolysaccharide biosynthesis and vitality metabolism have been enriched within the HRE group.

The current examine revealed that the sputum microbiome modified in COPD sufferers with completely different dangers of exacerbation. Moreover, the bacterial cooperative networks have been altered within the HRE sufferers and should contribute to illness exacerbation. Our outcomes present proof that sputum microbiome group dysbiosis is related to completely different COPD phenotypes, and we hope that by understanding the lung microbiome, a probably modifiable medical issue, additional targets for improved COPD therapies in the course of the clinically secure state could also be elucidated.

Analysis of cerebral dysfunction in sufferers with power kidney illness utilizing neuropsychometric and neurophysiological assessments

 Uremic encephalopathy is outlined as cerebral dysfunction on account of toxin accumulation in sufferers with power kidney illness (CKD). This situation is characterised by refined to florid signs, and its medical course is at all times progressive when untreated however partially reversible with renal alternative remedy. Whereas no check exists to measure subclinical uremic encephalopathy, two assessments have been validated to measure minimal hepatic encephalopathy: the crucial flicker frequency (CFF) check and the psychometric hepatic encephalopathy rating (PHES).
 This cross-sectional examine included a complete of 69 sufferers with stage-5 CKD. Cutoff factors for minimal encephalopathy have been established utilizing current medical tips: ≤39 Hz for CFF and < -Four for PHES. All members have been additionally screened for cognitive operate and melancholy. Eighteen circumstances (26.1%) of cerebral dysfunction linked to uremic encephalopathy have been detected with CFF, whereas twelve (17.4%) have been detected by PHES; solely six circumstances (8.7%) have been recognized by each strategies.
Half of the circumstances (50%) had diabetes, and 61% have been on hemodialysis. Cognitive operate scores didn’t differ considerably between these receiving dialysis, hemodialysis, or no renal alternative remedy. It’s important to determine cerebral dysfunction when uremic encephalopathy is in early subclinical phases to scale back preventable occasions as site visitors and work accidents. Mesenchymal stem cells (MSCs) in bone marrow (BM) stay unclear within the pathophysiology of cGVHD. On this examine, we analyzed BM-MSCs from 66 sufferers after allo-HSCT, together with 33 with lively cGVHD and 33 with out cGVHD.
Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state

Use of renin-angiotensin-aldosterone system blockade in controversial power kidney illness populations

Renin-angiotensin-aldosterone system blockers have proven to be efficient in controlling blood stress and proteinuria, slowing the development to finish stage renal illness and lowering cardiovascular danger, so they’re the mainstream therapy of hypertension in power kidney illness. Their helpful results have been confirmed in a number of randomized medical trials on completely different examine populations, however there has not too long ago been some controversial information on its use in some subgroups of sufferers, particularly these with superior power kidney illness.

Ammonia Assay Kit

55R-1410 100 assays
EUR 740
Description: Assay Kit for detection of Ammonia in the research laboratory

Ammonia Assay Kit

MET-5086 100 assays
EUR 456

ammonia electrode

ISE50B ea
EUR 454

TestStrip? Ammonia

M1091-100
EUR 294

TestStrip? Ammonia

M1091-200
EUR 436

TestStrip? Ammonia

M1091-50
EUR 207

Ammonia Colorimetric Assay Kit

K370-100
EUR 539

DISH,BIOASSAY,245MM SQUARE,S,BK,4/16

431272 4/pk
EUR 165
Description: Lab Cell Culture; BioAssay Dishes

Phenylalanine ammonia-lyase Assay Kit

abx097984-100Assays 100 Assays
EUR 535
  • Shipped within 5-10 working days.

Ammonia Colorimetric Assay Kit II

K470-100
EUR 539

Borane Ammonia Complex

abx188628-500g 500 g
EUR 1107
  • Shipped within 1-2 weeks.

calibration solution ammonia

ISC50 ea
EUR 91

Frit Kit

FRIT-KIT 1each
EUR 124
Description: Kit to create frits in capillaries. Includes formamide, Kasil-1, Kasil-1624 and a cleaving tool.

Column Packing Kit

PACK-KIT 1pack
EUR 1035
Description: Column packing kit for pressure cells. Includes: HPREG regulator, TBNG10 tubing, CAP-75 capillary, and STRB5X2 stir bar.

PCR Mycoplasma Detection Kit

M034-Kit Kit
EUR 266

Human Histidine Ammonia Lyase (HAL) ELISA Kit

DLR-HAL-Hu-48T 48T
EUR 479
  • Should the Human Histidine Ammonia Lyase (HAL) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Histidine Ammonia Lyase (HAL) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

DLR-HAL-Hu-96T 96T
EUR 621
  • Should the Human Histidine Ammonia Lyase (HAL) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Histidine Ammonia Lyase (HAL) in samples from tissue homogenates, cell lysates or other biological fluids.

Rat L Phenylalanine ammonia lyase ELISA kit

E02P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat L Phenylalanine ammonia lyase ELISA kit

E02P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat L Phenylalanine ammonia lyase ELISA kit

E02P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit L Phenylalanine ammonia lyase ELISA kit

E04P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit L Phenylalanine ammonia lyase ELISA kit

E04P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit L Phenylalanine ammonia lyase ELISA kit

E04P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse L Phenylalanine ammonia lyase ELISA kit

E03P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse L Phenylalanine ammonia lyase ELISA kit

E03P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse L Phenylalanine ammonia lyase ELISA kit

E03P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human L Phenylalanine ammonia lyase ELISA kit

E01P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human L Phenylalanine ammonia lyase ELISA kit

E01P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human L Phenylalanine ammonia lyase ELISA kit

E01P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Human L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

20-abx156887
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Dog L Phenylalanine ammonia lyase ELISA kit

E08P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Canine L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog L Phenylalanine ammonia lyase ELISA kit

E08P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Canine L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog L Phenylalanine ammonia lyase ELISA kit

E08P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Canine L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat L Phenylalanine ammonia lyase ELISA kit

E06P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat L Phenylalanine ammonia lyase ELISA kit

E06P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat L Phenylalanine ammonia lyase ELISA kit

E06P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig L Phenylalanine ammonia lyase ELISA kit

E07P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Porcine L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig L Phenylalanine ammonia lyase ELISA kit

E07P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Porcine L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig L Phenylalanine ammonia lyase ELISA kit

E07P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Porcine L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey L Phenylalanine ammonia lyase ELISA kit

E09P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Monkey L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey L Phenylalanine ammonia lyase ELISA kit

E09P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Monkey L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey L Phenylalanine ammonia lyase ELISA kit

E09P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Monkey L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Histidine Ammonia-Lyase (HAL) ELISA Kit

abx391456-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Human Histidine Ammonia Lyase (HAL) CLIA Kit

20-abx495586
  • EUR 7973.00
  • EUR 4246.00
  • EUR 981.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Please enquire.

Mouse Histidine Ammonia-Lyase (HAL) ELISA Kit

abx389551-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

RDR-HAL-Hu-48Tests 48 Tests
EUR 500

Human Histidine Ammonia Lyase (HAL) ELISA Kit

RDR-HAL-Hu-96Tests 96 Tests
EUR 692

Human Histidine Ammonia Lyase (HAL) ELISA Kit

RD-HAL-Hu-48Tests 48 Tests
EUR 478

Human Histidine Ammonia Lyase (HAL) ELISA Kit

RD-HAL-Hu-96Tests 96 Tests
EUR 662

Human Histidine Ammonia Lyase (HAL) ELISA Kit

SEH932Hu-10x96wellstestplate 10x96-wells test plate
EUR 4731.5
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Histidine Ammonia Lyase (HAL) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Histidine Ammonia Lyase (HAL) in Tissue homogenates, cell lysates and other biological fluids.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

SEH932Hu-1x48wellstestplate 1x48-wells test plate
EUR 477.3
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Histidine Ammonia Lyase (HAL) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Histidine Ammonia Lyase (HAL) in Tissue homogenates, cell lysates and other biological fluids.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

SEH932Hu-1x96wellstestplate 1x96-wells test plate
EUR 639
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Histidine Ammonia Lyase (HAL) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Histidine Ammonia Lyase (HAL) in Tissue homogenates, cell lysates and other biological fluids.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

SEH932Hu-5x96wellstestplate 5x96-wells test plate
EUR 2575.5
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Histidine Ammonia Lyase (HAL) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Histidine Ammonia Lyase (HAL) in Tissue homogenates, cell lysates and other biological fluids.

Human Histidine Ammonia Lyase (HAL) ELISA Kit

4-SEH932Hu
  • EUR 4782.00
  • EUR 2526.00
  • EUR 640.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
  • Known also as Histidine Ammonia Lyase elisa. Alternative names of the recognized antigen: HIS
  • Histidase
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Histidine Ammonia Lyase (HAL) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.

Cas9 Protein and T7 gRNA SmartNuclease Synthesis Kit

CAS400A-KIT 1 kit (10 rxn)
EUR 1110
  • Category: Cas9

CMV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV100PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

CMV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV105PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

MSCV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV120PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

MSCV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV125PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

Histidine Ammonia-Lyase (HAL) Antibody

20-abx334175
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Multiplex gRNA Kit + EF1-T7-hspCas9-H1-gRNA linearized SmartNuclease vector

CAS700A-KIT 10 rxn
EUR 1132
  • Category: Cas9

Multiplex gRNA Kit + CAG-T7-hspCas9-H1-gRNA linearized SmartNuclease vector

CAS720A-KIT 10 rxn
EUR 1132
  • Category: Cas9

Multiplex gRNA Kit + CMV-T7-hspCas9-H1-gRNA linearized SmartNuclease vector

CAS740A-KIT 10 rxn
EUR 1132
  • Category: Cas9

T7 gRNA SmartNuclease Synthesis Kit (includes CAS510A-1 & T7 IVT synthesis reagents)

CAS510A-KIT 1 Kit
EUR 805
  • Category: Cas9

Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV200PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

Cas9 Nickase: CMV-hspCas9(D10A)-EF1-GFP SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV205PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV220PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

Cas9 Nickase: MSCV-hspCas9(D10A)-EF1-GFP SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV225PA-KIT 1 Kit
EUR 1132
  • Category: Cas9

Multiplex gRNA Kit + Cas9 Nickase: EF1-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector

CAS750A-KIT 10 rxn
EUR 1132
  • Category: Cas9

Multiplex gRNA Kit + Cas9 Nickase: CAG-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector

CAS770A-KIT 10 rxn
EUR 1132
  • Category: Cas9

Multiplex gRNA Kit + Cas9 Nickase: CMV-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector

CAS790A-KIT 10 rxn
EUR 1132
  • Category: Cas9

Cas9 SmartNuclease Extra Ligation Kit [includes 5x ligation buffer (10 ul) and Fast ligase (2.5ul)]

CAS9LIG-KIT 1 Kit
EUR 153
  • Category: Cas9

Hal ELISA Kit| Rat Histidine ammonia-lyase ELISA Kit

EF018814 96 Tests
EUR 689

Hal ELISA Kit| Mouse Histidine ammonia-lyase ELISA Kit

EF015185 96 Tests
EUR 689

HAL ELISA Kit| Bovine Histidine ammonia-lyase ELISA Kit

EF011495 96 Tests
EUR 689

PinPoint-FC 293T Platform Kit for Targeted Gene Insertion (includes PIN320A-1, PIN200A-1, PIN510A-1 & PIN600A-1)

PIN320A-KIT 1 Kit
EUR 4941
  • Category: PinPoint Integrase Tools

Guinea pig L Phenylalanine ammonia lyase ELISA kit

E05P0597-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Guinea pig L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig L Phenylalanine ammonia lyase ELISA kit

E05P0597-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Guinea pig L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig L Phenylalanine ammonia lyase ELISA kit

E05P0597-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Guinea pig L Phenylalanine ammonia lyase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Bovine HAL (Histidine ammonia-lyase) ELISA Kit (CUSTOM)

ELI-14312b 96 Tests
EUR 928

Mouse HAL (Histidine ammonia-lyase) ELISA Kit (CUSTOM)

ELI-20226m 96 Tests
EUR 865

ELISA kit for Human HAL (Histidine Ammonia Lyase)

ELK5180 1 plate of 96 wells
EUR 432
  • The microtiter plate provided in this kit has been pre-coated with an antibody specific to Histidine Ammonia Lyase (HAL). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Hist
  • Show more
Description: A sandwich ELISA kit for detection of Histidine Ammonia Lyase from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Mouse L-Phenylalanine ammonia-lyase (PAL) ELISA Kit

abx350370-96tests 96 tests
EUR 668
  • Shipped within 5-12 working days.

Rat HAL (Histidine ammonia-lyase) ELISA Kit (CUSTOM)

ELI-38660r 96 Tests
EUR 886

Human HAL (Histidine ammonia-lyase) ELISA Kit (CUSTOM)

ELI-48714h 96 Tests
EUR 824

PinPoint-FC Murine iPSC Platform Kit for Targeted Gene Insertion (includes PIN340iPS-1, PIN200A-1, PIN510A-1 & PIN600A-1)

PIN340iPS-KIT 1 Kit
EUR 4941
  • Category: PinPoint Integrase Tools

Ethanolamine ammonia-lyase light chain Antibody

20-abx110555
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Histidine Ammonia-Lyase (HAL) Antibody (HRP)

20-abx335961
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Histidine Ammonia-Lyase (HAL) Antibody (FITC)

20-abx335962
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Histidine Ammonia-Lyase (HAL) Antibody (Biotin)

20-abx335963
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

L-Phenylalanine Ammonia-Lyase (pal) Antibody

20-abx300213
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Ammonia hydroxide, 28% solution in water

GE1331-1L 1 l
EUR 58

Ammonia hydroxide, 25% solution in water

GE3336-1L 1 l
EUR 57

AAVS1 Safe Harbor Targeting Vector 2.0 - All-Purpose Donor (AAVS1-SA-puro-MCS), Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector) and GE640PR-1 (Junction PCR Primer Mix to confirm AAVS1 integration site)

GE620A-KIT 1 kit
EUR 2132
  • Category: Gene Editing

AAVS1 Safe Harbor Targeting Vector 2.0 - GOI Knock-in Donor (AAVS1-SA-puro-EF1-MCS), Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector) and GE640PR-1 (Junction PCR Primer Mix to confirm AAVS1 integration site)

GE622A-KIT 1 kit
EUR 2132
  • Category: Gene Editing

AAVS1 Safe Harbor Targeting Vector 2.0 - Reporter Knock-in Donor (AAVS1-SA-puro-MCS-GFP), Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector) and GE640PR-1 (Junction PCR Primer Mix to confirm AAVS1 integration site)

GE624A-KIT 1 kit
EUR 2132
  • Category: Gene Editing

Rat Carbamoyl phosphate synthase [ammonia], mitochondrial(CPS1) ELISA kit

E02C2022-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A competitive ELISA for quantitative measurement of Rat Carbamoyl phosphate synthase [ammonia], mitochondrial(CPS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

In another populations equivalent to sufferers with non-proteinuric nephropathies or the aged, who may be extra vulnerable to its adversarial occasions, their advantages have additionally been questioned. The intention of the current evaluation is to gather accessible printed information on the impact of renin-angiotensin-aldosterone system blockers in some controversial populations and supply perspective on future analysis areas on this subject. Continual graft-versus-host illness (cGVHD) is the principle reason for non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT).

 

Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial

Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial
Continual obstructive pulmonary illness (COPD) is a continual inflammatory lung illness characterised by coughing, the manufacturing of extra sputum, and dyspnea. Sufferers with excessively thick sputum could have frequent assaults or develop extra severe illness. The rules advocate airway clearance for sufferers with extreme sputum who’re hospitalized with COPD. The lively cycle of respiratory approach is the commonest non-pharmacological airway clearance approach utilized by physiotherapists. Nevertheless, the effectiveness of the approach shouldn’t be at all times assured. Energetic cycle of respiratory methods require the preliminary dilution of the sputum, normally by inhalation medicine, which can have restricted results.
 We suggest a single-blind randomized managed trial utilizing 75 hospitalized sufferers recognized with COPD with extreme sputum manufacturing. The sufferers might be divided into three teams. The intervention group will obtain lively cycle of respiratory methods mixed with phonophoresis. The 2 comparability teams might be handled with lively cycle of respiratory methods and phonophoresis, respectively. This system might be applied day by day for 1 week. The first outcomes might be adjustments in sputum viscosity and manufacturing, lung operate, and pulse oximetry.
Secondary outcomes embody the evaluation of COPD and anxiousness, measured by the COPD Evaluation Take a look at scale and the Nervousness Stock for Respiratory Illness, respectively; self-satisfaction; the diploma of cooperation; and the size of hospital keep. All final result measures, except for sputum manufacturing and extra secondary outcomes, might be assessed on the graduation of the examine and after 1 week’s intervention. Evaluation of variance might be used to research variations between the teams, and a p-value of lower than 0.05 (two-tailed) might be thought-about statistically vital.
Current research have discovered that phonophoresis decreases irritation, suggesting the potential of the mixed utilization of lively cycle of respiratory methods and phonophoresis. Subsequently, the intention of this examine is to discover the effectiveness and security of mixing lively cycle of respiratory approach and phonophoresis in treating COPD sufferers. This examine introduces a mixture of lively cycle of respiratory methods and phonophoresis to discover the affect of those interventions on sufferers hospitalized with COPD. If this mixed intervention is proven to be efficient, it could show to be a greater therapy for sufferers with COPD.

The impact of consecutive ambient air air pollution on the hospital admission from continual obstructive pulmonary illness within the Chengdu area, China

Hospitalisation dangers for continual obstructive pulmonary illness (COPD) have been attributed to ambient air air pollution worldwide. Nevertheless, an increase in COPD hospitalisations could point out a substantial enhance in fatality charge in public well being. The present examine focuses on the affiliation between consecutive ambient air air pollution (CAAP) and COPD hospitalisation to supply predictable early steering in the direction of estimates of COPD hospital admissions within the occasion of consecutive publicity to air air pollution.

Massive knowledge analytics had been collected from 3-year time collection recordings (from 2015 to 2017) of each air knowledge and COPD hospitalisation knowledge within the Chengdu area in China. Based mostly on the mixed results of CAAP and unit enhance in air pollutant concentrations, a quasi-Poisson regression mannequin was established, which revealed the affiliation between CAAP and estimated COPD admissions. The outcomes present the dynamics and outbreaks within the variations in COPD admissions in response to CAAP. Cross-validation and imply squared error (MSE) are utilized to validate the goodness of match.

In each short-term and long-term air air pollution exposures, Z check outcomes present that the COPD hospitalisation threat is larger for males than for ladies; equally, the prevalence of COPD hospital admissions within the group of aged individuals (> 65 years outdated) is considerably bigger than that in decrease age teams. The time lag between the air high quality and COPD hospitalisation can also be investigated, and a peak of COPD hospitalisation threat is discovered to lag 2 days for air high quality index (AQI) and PM10, and 1 day for PM2.5. The massive data-based predictive paradigm could be a measure for the early detection of a public well being occasion in post-COVID-19. The examine findings also can present steering for COPD admissions within the occasion of consecutive publicity to air air pollution within the Chengdu area.

Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial

Harnessing cell well being know-how to help lengthytime period continual sickness administration: exploring household caregiver help wants within the outpatient setting

 Household caregiving is a crucial public well being subject, significantly with the getting old inhabitants. Lately, cell well being (mHealth) know-how has emerged as a possible low-cost, scalable platform to handle caregiver help wants, and thereby alleviate the burden on caregivers. This examine sought to look at the help wants of household caregivers of their lived experiences of outpatient care to tell the event of a future mHealth intervention. We performed 20 semi-structured interviews in 2 outpatient hematopoietic cell transplant (HCT) clinics at a big tutorial medical heart within the Midwestern United States. A thematic evaluation was carried out to outline rising themes.
Qualitative knowledge evaluation recognized 5 main themes that HCT caregivers confronted: (I) life-style restrictions as a result of affected person’s immunocompromised state; (II) Unmet wants attributable to limitations within the present assets, together with unfamiliar medical duties with out crucial trainings; and (III) caregivers’ adaptive methods, together with reformation of social relationships with household and buddies. Based mostly on these findings, we recommend Three design issues to information the event of a future mHealth intervention.
Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E02C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E02C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E02C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E03C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E03C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E03C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E06C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E06C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E06C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E04C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E04C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E04C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E07C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E07C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E07C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E09C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E09C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E09C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E08C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E08C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E08C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E05C1802-192T 192 tests
EUR 1270
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E05C1802-48 1 plate of 48 wells
EUR 520
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit
E05C1802-96 1 plate of 96 wells
EUR 685
  • Kit contents: 1. MICROTITER PLATE * 1 2. ENZYME CONJUGATE*1 vial 3. STANDARD A*1 vial 4. STANDARD B*1 vial 5. STANDARD C*1 vial 6. STANDARD D*1 vial 7. STANDARD E*1 vial 8. STANDARD F*1 vial 9. SUBSTRATE A*1 vial 10. SUBSTRATE B*1 vial 11. STOP SOLUT
  • Show more
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Anti-ZAP70 (Chronic Lymphocytic Leukemia Marker) Monoclonal Antibody
M00754-1 100ug/vial
EUR 397
Description: Mouse Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody. Validated in IHC and tested in Human.
ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)
RA0453-C.1 0.1 ml
EUR 125
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNUB2035-100 100uL
EUR 264
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNUB2035-50 50uL
EUR 405
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNUB2035-500 500uL
EUR 513
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Concentration: 0.2mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNUB2046-100 100uL
EUR 264
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNUB2046-50 50uL
EUR 405
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNUB2046-500 500uL
EUR 513
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Concentration: 0.2mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC552035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC552035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC552046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC552046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC612035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC612035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC612046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC612046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC472035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC472035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC472046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC472046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC042035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC042035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405S conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC042046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC042046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405S conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC052035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC052035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC052046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC052046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC402035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC402035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF640R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC402046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC402046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF640R conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC432035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC432035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC432046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC432046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC702035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC702035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC702046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC702046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC802035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC802035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC802046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC802046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCH2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCH2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCH2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCH2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCP2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), PerCP conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCP2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), PerCP conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCR2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), RPE conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCR2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), RPE conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC942035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC942035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC942046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC942046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF594 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCA2035-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), APC conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCA2046-250 250uL
EUR 394
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), APC conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCB2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Biotin conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCB2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Biotin conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCB2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Biotin conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCB2046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Biotin conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC882035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF488A conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC882035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF488A conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC882046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF488A conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC882046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF488A conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC682035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC682035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC682046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC682046-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCAP2035-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNCAP2035-500 500uL
EUR 545
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNCAP2046-100 100uL
EUR 233
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
The findings herein captured the household caregiver’s lived experiences throughout outpatient care. There was broad settlement that caregiving was difficult and disturbing. Thus, efficient and scalable interventions to help caregivers are wanted. This examine offered knowledge to information the content material and design of a future mHealth intervention within the outpatient setting.

Recent advances in pharmacological interventions of chronic prostatitis/chronic pelvic pain syndrome

Recent advances in pharmacological interventions of chronic prostatitis/chronic pelvic pain syndrome

Persistent prostatitis/power pelvic ache syndrome sort III is expounded to irritative void-ing, sexual dysfunction and pelvic ache. Persistent prostatitis/power pelvic ache syn-drome weakens the standard of life and poses hostile psychological results on the pa-tients. A variety of therapies, together with botulinum neurotoxins, anti-inflammatories, alpha-blockers, phytotherapy, 5α-reductase inhibitors, phos-phodiesterase sort Four inhibitor, phosphodiesterase sort 5 inhibitor, monoclonal anti-body, anticholinergics, gabapentin, pregabalin are used clinically. These therapies em-phasise on easing the signs in particular areas with out curing the elemental trigger the place the end result of the therapy just isn’t utterly passable.

This assessment article explains the current pharmacological therapies of power prostatitis/power pelvic ache syndrome intimately and gives a future perspective to deal with this situation. Descriptive-correlational and cross-sectional quantitative examine. Performed in a hospital in central Portugal, between January and June 2013. A comfort pattern of 307 power sufferers was chosen. The variables collected by way of the questionnaire had been: age, intercourse, marital standing, employment standing, month-to-month revenue, notion of household functioning (Smilkinstein), medical pathology, spirituality (Pinto and Pais-Ribeiro) and diploma of struggling (McIntyre and Gameiro). The mission was permitted by the hospital’s ethics committee.

The contributors signed an knowledgeable consent type. The worldwide struggling of power sufferers studied on the hospital stage is average (M=3.01), on a scale of 1 to five, with the psychological dimension being probably the most affected (M=3.18). Aged sufferers undergo extra bodily and have extra constructive experiences. Girls current better socio-relational and psychological struggling. Then again, individuals who reside alone, with a month-to-month revenue of lower than 300 euros, with a low stage of training, with the notion of belonging to a dysfunctional household and with neurological pathology, undergo probably the most. A number of linear regression confirmed that spirituality is considerably inversely correlated with struggling. Beliefs are liable for 6.0% of the defined variance of struggling and hope / optimism for 3.3%.

Acute Stroke Look after Sufferers with Persistent Kidney Illness

Persistent kidney illness is a standard comorbidity in sufferers presenting to emergency departments with acute ischemic stroke. There are quite a few concerns that should be taken under consideration within the acute analysis and administration of those sufferers. CKD sufferers could have completely different stroke shows in comparison with the final inhabitants that will make analysis tougher. With the increasing use of endovascular thrombectomy for acute ischemic stroke, extra contrasted research are being employed as a part of the acute analysis, significantly within the identification of sufferers with massive vessel occlusion and demonstration of salvageable penumbra.

Though affected person outcomes with reperfusion therapies comparable to intravenous alteplase and endovascular thrombectomy aren’t as sturdy as these seen inside the common inhabitants, the accessible information helps utilization of those therapies amongst CKD sufferers. This text offers a assessment of the elements that should be thought of within the acute administration of the CKD affected person presenting with acute ischemic stroke. We searched Scopus, PubMed, Cochrane, and Internet of Science databases until August 2020 and up to date the search in December 2020 utilizing related key phrases. All search outcomes had been screened for eligibility.

We extracted the info from the included articles and pooled them as imply distinction (MD) with a 95% confidence interval (CI), utilizing Overview Supervisor software program (ver. 5.4). Quite the opposite, pulmonary N-cadherin, Vimentin and α-SMA, three of mesenchymal biomarkers, have been elevated in COPD sufferers with larger circulatory Cd. In vitro experiments revealed that Cd publicity repressed miR-30 ranges and promoted EMT in BEAS-2B cells.  For many sufferers with renal dysfunction, research comparable to CT angiography and perfusion should still be carried out regardless of issues of acute kidney damage.

Recent advances in pharmacological interventions of chronic prostatitis/chronic pelvic pain syndrome

The Relationship Between the Wholesome Weight loss plan Index, Persistent Illnesses, Weight problems and Way of life Danger Components Amongst Adults in Kaunas Metropolis, Lithuania

A wholesome and balanced weight-reduction plan is a crucial issue contributing to total well being and wellness. The purpose of this examine was to develop a Wholesome Weight loss plan Index (HDI) rating and assess its affiliation with numerous power illnesses and way of life threat elements. A cross-sectional survey included 1,111 adults aged 18 years and older. Data on dietary habits was collected utilizing a questionnaire. Extra demographic, socioeconomic and way of life threat elements information had been additionally collected. Sixteen meals teams had been used to develop the HDI rating for the residents of Kaunas metropolis, Lithuania primarily based on the nationwide suggestions

World Well being Group (WHO) and different steerage on a nutritious diet. We used logistic regression fashions to evaluate the affiliation of the HDI rating with power illnesses, weight problems and way of life threat elements. We discovered that each women and men had been missing the optimum consumption of the bottom parts of a wholesome diet-fruits and greens, starchy carbohydrates, and proteins. We additionally noticed vital associations between the HDI rating and several other outcomes comparable to hypertension, arrhythmia, bodily exercise, and weight problems. The recommended HDI rating may function a helpful instrument in assessing and enhancing dietary habits helpful for selling well being and stopping many illnesses.

In addition to pulmonary dysfunctions, sufferers with power obstructive pulmonary illness (COPD) additionally incessantly have systemic comorbidities. Amongst these, sarcopenia is related to worse pulmonary perform and medical outcomes. Sufferers with acute exacerbated COPD (AECOPD) have elevated systemic irritation, which may intensify muscle dysfunction. Subsequently, the current examine aimed to guage the prevalence of sarcopenia in AECOPD sufferers and assess the related elements and their prognostic worth. As a secondary purpose, we additionally assessed the efficiency of calf circumference (CC) to diagnose this situation.